Compelling evidence showed that transforming growth factor β (TGF-β) is a potent inducer of EMT and chemoresistance in multiple cancers, including PCa, through small mothers against decapentaplegic homolog-independent or homolog-dependent signaling pathway (9, 32, 43–47). This evidence concerns the gene TGFB1 and posterior cortical atrophy.